세계의 첨단 시각화 시장 : 제공별, 솔루션 유형별, 영상 모달리티별, 용도별, 최종사용자별, 지역별 - 예측(-2029년)

Advanced Visualization Market by Type (Enterprise, Standalone), Modality (MRI, CT, PET, Ultrasound, Radiotherapy, Nuclear Medicine), Application (Radiology, Oncology, Neuro), End User (Hospital, ASC, Diagnostic Center) & Region - Global Forecast to 2029

US $ 4,950 ￦ 7,024,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,437,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,565,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,191,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

전 세계 첨단 시각화 시장 규모는 2024년 37억 8,000만 달러에서 2029년에는 65억 5,000만 달러에 달할 것으로 예상되며, 예측 기간 동안 연평균 11.7%의 CAGR을 기록할 것으로 예상됩니다.

이 시장은 공공 및 민간 기관의 투자 및 자금 지원 증가, 심장학, 방사선학, 신경학, 종양학 등 다양한 분야에서 기술적으로 진보된 시각화 솔루션에 대한 수요가 급증함에 따라 성장할 것으로 예상됩니다. 또한, 헬스케어 산업 전반에 걸쳐 영상 처리 기술 향상에 대한 요구가 증가함에 따라 시장이 성장하고 있습니다. 그러나 IT 인프라가 부족하고 신흥국의 경우 첨단 시각화 솔루션 도입에 소극적이라는 점이 시장 성장에 걸림돌로 작용할 것으로 예상됩니다.

조사 범위
조사 대상 연도	2022-2029년
기준 연도	2023년
예측 기간	2024-2029년
검토 단위	금액(달러)
부문	제품별, 솔루션 유형별, 영상 모달리티별, 용도별, 최종사용자별, 지역별
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카

첨단 시각화 소프트웨어 부문은 온프레미스 및 클라우드 기반으로 세분화되며, 2023년에는 클라우드 기반 부문이 예측 기간 동안 가장 높은 성장률을 기록할 것으로 예상됩니다. 클라우드 부문의 성장은 다양한 사일로의 원활한 데이터 통합, 원격지에서의 무제한 사용자 액세스, 낮은 유지보수 비용, 높은 보안, 프라이버시, 쉬운 접근성, 하드웨어에 대한 선투자 불필요, 높은 유연성, 최적화된 리소스 활용 등 클라우드 기반 소프트웨어가 제공하는 많은 장점에 기인합니다. 이 모델이 제공하는 많은 장점에 기인합니다. 또한, 원격의료 서비스 및 원격의료 솔루션에 대한 수요가 증가함에 따라, 영상 처리 도구에 쉽게 접근하고 의료진 간의 데이터 공유를 용이하게 하는 클라우드 기술의 채택이 가속화되어 이 분야의 성장에 더욱 기여하고 있습니다.

병원 및 외래 수술 센터, 진단 및 영상 센터, 학술 및 연구 센터, 기타 최종사용자는 첨단 시각화 시장의 최종사용자 부문을 구성하고 있으며, 2023년에는 병원 및 외래 수술 센터가 최종사용자별로 첨단 시각화 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다. 또한, 이 부문은 예측 기간 동안 가장 큰 성장을 기록할 것으로 예상됩니다. 이 부문의 높은 성장세는 영상 데이터의 복잡성 증가, 정확한 진단 및 수술 계획에 대한 수요, 최소침습 수술의 증가, 기존 시스템과의 상호운용성 필요성 등이 주요 요인으로 작용하고 있습니다. 또한, 개인화된 의료와 정밀 치료의 발전, AI와 머신러닝의 통합은 의료 서비스 제공자 산업에서 고급 가시성의 가치를 더욱 높이고 있습니다.

첨단 시각화 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 나뉩니다. 아시아태평양은 예측 기간 동안 가장 높은 성장률을 기록할 것으로 예상됩니다. 아시아태평양의 높은 성장 배경에는 이 지역의 대규모 환자 인구 증가, 혁신적인 치료법에 대한 수요 증가, 헬스케어 빅데이터의 등장, HCIT 인프라에 대한 지출 증가, 다양한 시장 기업의 신흥 국가로의 초점 이동 등이 있습니다. 헬스케어 산업 전반에 걸쳐 디지털 및 기술 지원 솔루션의 채택을 촉진하기 위한 정부의 노력과 워크플로우 전반에 걸친 첨단 기술 통합에 대한 관심이 높아진 것도 성장에 기여하고 있습니다.

이 보고서는 세계 첨단 시각화 시장을 조사하여 제공별, 솔루션 유형별, 이미지 모달리티별, 용도별, 최종사용자별, 지역별 동향, 시장 진입 기업 개요 등을 정리한 보고서입니다.

목차

제1장 소개

제2장 조사 방법

제3장 주요 요약

제4장 주요 인사이트

제5장 시장 개요

• 소개
• 시장 역학
• 고객의 비즈니스에 영향을 미치는 동향/혼란
• 가격 분석
• 밸류체인 분석
• 생태계 분석
• 투자와 자금 조달 시나리오
• 기술 분석
• 업계 동향
• 특허 분석
• 2025-2026년의 주요 회의와 이벤트
• 사례 연구 분석
• 규제 상황
• Porter's Five Forces 분석
• 주요 이해관계자와 구입 기준
• 최종사용자 분석
• 첨단 시각화 비즈니스 모델
• 첨단 시각화 시장의 AI/생성형 AI의 영향

제6장 첨단 시각화 시장, 제공별

• 소개
• 서비스
• 소프트웨어
• 하드웨어

제7장 첨단 시각화 시장, 솔루션 유형별

• 소개
• 기업 전체에서의 씬 클라이언트 기반 솔루션
• 독립형 워크스테이션 기반 솔루션

제8장 첨단 시각화 시장, 영상 모달리티별

• 소개
• 자기공명영상
• 컴퓨터 단층촬영
• 양전자 방출 단층촬영
• 초음파
• 방사선 치료
• 핵의학
• 기타

제9장 첨단 시각화 시장, 용도별

• 소개
• 방사선/개입 방사선
• 심장병
• 정형외과
• 종양과
• 혈관과
• 신경과
• 기타

제10장 첨단 시각화 시장, 최종사용자별

• 소개
• 병원·외래 수술 센터
• 진단·영상 진단 센터
• 학술 연구 센터
• 기타

제11장 첨단 시각화 시장, 지역별

• 소개
• 북미
  • 북미의 거시경제 전망
  • 미국
  • 캐나다
• 유럽
  • 유럽의 거시경제 전망
  • 독일
  • 영국
  • 프랑스
  • 스페인
  • 이탈리아
  • 기타
• 아시아태평양
  • 아시아태평양의 거시경제 전망
  • 일본
  • 중국
  • 인도
  • 기타
• 라틴아메리카
  • 라틴아메리카의 거시경제 전망
  • 브라질
  • 멕시코
  • 기타
• 중동 및 아프리카
  • 중동 및 아프리카의 거시경제 전망
  • GCC 국가
  • 기타

제12장 경쟁 구도

• 개요
• 주요 진출 기업 전략/강점, 2021년 1월-2024년 12월
• 매출 분석, 2019-2023년
• 시장 점유율 분석, 2023년
• 기업 가치 평가와 재무 지표
• 브랜드/제품 비교
• 기업 평가 매트릭스 : 주요 진출 기업, 2023년
• 기업 평가 매트릭스 : 스타트업/중소기업, 2023년
• 경쟁 시나리오

제13장 기업 개요

• 주요 진출 기업
  • AGFA-GEVAERT GROUP
  • CANON MEDICAL SYSTEMS CORPORATION
  • FUJIFILM HOLDINGS CORPORATION
  • GE HEALTHCARE
  • SIEMENS HEALTHINEERS AG
  • KONINKLIJKE PHILIPS N.V.
  • STRYKER
  • CHANGE HEALTHCARE(UNITEDHEALTH GROUP)
  • TERARECON
  • ZIOSOFT
  • PRO MEDICUS, LTD.
  • CARESTREAM HEALTH
  • FOVIA, INC.
  • 4DMEDICAL
  • SYNOPSYS, INC.
  • NOVARAD
  • ANALYZEDIRECT, INC.
  • SYNTERMED INC.
  • PIE MEDICAL IMAGING B.V.
  • INFINITT HEALTHCARE CO., LTD.
• 기타 기업
  • BIOTRONICS 3D
  • MINNOVAA INNOVATIONS OU
  • POSTDICOM
  • CITIUSTECH INC.
  • CEEVRA, INC.

제14장 부록

KSM

영문 목차

영문목차

The global Advanced visualization market is projected to reach USD 6.55 billion by 2029 from USD 3.78 billion in 2024, at a CAGR of 11.7% during the forecast period. The market is expected to grow as a result of the increasing investments & fundings by public-private organizations, surging demand for technologically advanced visualization solutions for various applications across the industry, such as, cardiology, radiology, neurology, oncology, among others. Moreover, the market has experienced growth due to the need for improved imaging techniques across healthcare industry. However, insufficient IT infrastructure, and reluctance towards adoption of advanced visualization solutions in emerging economies are some of the factors that are expected to pose a challenge to the market growth.

Scope of the Report
Years Considered for the Study	2022-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD)
Segments	Offering, Solution Type, Imaging Modality, Application, and End User
Regions covered	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

"Cloud-based subsegment, under the advanced visualization software segment is expected to register highest growth during the forecast period."

The advanced visualization software segment is sub-segmented into on-premise and cloud-based. In 2023, the cloud-based segment is expected to register the highest growth during the forecast period. The growth of the cloud segment is attributed to the ample number of advantages offered by this model, such as the seamless integration of data from various silos, unlimited user access from remote locations, low maintenance costs, high security, privacy, easy accessibility, no upfront capital investment for hardware, and extreme capacity flexibility and optimized resource utilization. Moreover, the increasing demand for remote healthcare services and telemedicine solutions has accelerated the adoption of cloud technologies that facilitate easy access to imaging tools and data sharing among healthcare professionals, further contributing to the segment's growth.

"Hospitals & Ambulatory Surgical Centers is projected to dominate the market in the advanced visualization market, by end user during the forecast period."

The hospitals & ambulatory surgical centers, diagnostic & imaging centers, academic & research centers, and other end users make up the end user segments of the advanced visualization market. In 2023, the hospitals & ambulatory surgical centers accounted for a significant share of the advanced visualization market, by end user. The segment is also expected to register paramount growth during the forecast period. The prominent position & high growth of this segment is due to the increasing complexity of imaging data, demand for precise diagnostics & surgical planning, rise in minimally-invasive procedures, and the need for interoperability with existing systems. Moreover, the push for personalized medicine and precision therapeutics, the integration of AI and machine learning further strengthens the value of advanced visualization in the provider industry.

"Asia Pacific is expected to register highest market growth during the forecast period."

The advanced visualization market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region is expected to register highest growth during the forecast period. The high growth of this region is attributed to the the presence of a large and growing patient population in the region, the increasing need for innovative therapies, the emergence of big data in healthcare, increasing spending on HCIT infrastructure, and the shifting focus of various market players on emerging countries in the region. Government initiatives to promote the adoption of digital & technologically enabled solutions across healthcare industry, and significant focus on integrating sophisticated technologies across the workflows also contributes to the growth.

The break-down of primary participants is as mentioned below:

• By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
• By Designation - Directors: 30%, Manager: 34%, and Others: 36%
• By Region - North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7% and Middle East & Africa: 5%

List of Companies Profiled in the Report

• Agfa-Gevaert Group (Belgium)
• Canon Medical Systems Corporation (Japan)
• Fujifilm Holdings Corporation (Japan)
• GE Healthcare (US)
• Koninklijke Philips N.V. (Netherlands)
• Siemens Healthineers AG (Germany)
• Stryker (US)
• Change Healthcare (US)
• TeraRecon (US)
• Ziosoft (Japan)
• Pro Medicus, Ltd (Australia)
• Carestream Health (US)
• Fovia, Inc. (US)
• 4DMedical (Australia)
• Synopsys, Inc. (US)
• Novarad (US)
• AnalyzeDirect, Inc. (US)
• Syntermed Inc. (Netherlands)
• Pie Medical Imaging B.V. (Netherlands)
• Infinitt Healthcare Co., Ltd. (US)
• Biotronics 3D (UK)
• Minnovaa Innovations Ou (Estonia)
• Postdicom (Netherlands)
• CitiusTech Inc (US)
• Ceevra, Inc. (US)

Research Coverage:

The report analyzes the advanced visualization market and aims to estimate the market size and future growth potential of various market segments, based on offering, solution type, imaging modality, applicarion, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total advanced visualization market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

• Analysis of key drivers (booming geriatric population, growing advancements in picture archiving and communication systems and advanced visualization, rising investments by government and private organizations, increasing need for early disease diagnosis), restraints (limited availability of reimbursements, high deployment cost of advanced visualization tools), opportunities (expanding modernization efforts in emerging economies, growing adoption of artificial intelligence and machine learning, increasing establishment of hospitals and diagnostic imaging centers), challenges (shortage of skilled personnel, declining budget allocation for health services) are factors contributing the growth of the advanced visualization market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the advanced visualization market.
• Market Development: Comprehensive information on the lucrative emerging markets, type of solution, component, deployment model, industry, and region.
• Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the advanced visualization market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global advanced visualization market such as Agfa-Gevaert Group (Belgium), Canon Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6.2 SCOPE-RELATED LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ADVANCED VISUALIZATION MARKET OVERVIEW
• 4.2 ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY OFFERING AND COUNTRY
• 4.3 ADVANCED VISUALIZATION MARKET, BY COUNTRY
• 4.4 ADVANCED VISUALIZATION MARKET: REGIONAL MIX
• 4.5 ADVANCED VISUALIZATION MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Booming geriatric population
    • 5.2.1.2 Growing advancements in picture archiving and communication systems and advanced visualization
    • 5.2.1.3 Rising investments by government and private organizations
    • 5.2.1.4 Increasing need for early disease diagnosis
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Limited availability of reimbursements
    • 5.2.2.2 High deployment cost of advanced visualization tools
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Expanding modernization efforts in emerging economies
    • 5.2.3.2 Growing adoption of artificial intelligence and machine learning
    • 5.2.3.3 Increasing establishment of hospitals and diagnostic imaging centers
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Shortage of skilled personnel
    • 5.2.4.2 Declining budget allocation for health services
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.4 PRICING ANALYSIS
  • 5.4.1 INDICATIVE SELLING PRICE, BY OFFERING
  • 5.4.2 INDICATIVE SELLING PRICE, BY REGION
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 ECOSYSTEM ANALYSIS
• 5.7 INVESTMENT AND FUNDING SCENARIO
• 5.8 TECHNOLOGY ANALYSIS
  • 5.8.1 KEY TECHNOLOGIES
    • 5.8.1.1 Machine learning and artificial intelligence
    • 5.8.1.2 Augmented reality and virtual reality
    • 5.8.1.3 Cloud computing
  • 5.8.2 COMPLEMENTARY TECHNOLOGIES
    • 5.8.2.1 Bioinformatics tools
    • 5.8.2.2 Big data analytics
    • 5.8.2.3 Internet of things
  • 5.8.3 ADJACENT TECHNOLOGIES
    • 5.8.3.1 Blockchain
    • 5.8.3.2 Quantum computing
• 5.9 INDUSTRY TRENDS
  • 5.9.1 INTEGRATION OF ADVANCED VISUALIZATION SOLUTIONS WITH DATA-SHARING MODALITIES
  • 5.9.2 INTEGRATION OF ADVANCED VISUALIZATION SOLUTIONS WITH PICTURE ARCHIVING AND COMMUNICATION SYSTEMS
• 5.10 PATENT ANALYSIS
• 5.11 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.12 CASE STUDY ANALYSIS
  • 5.12.1 ENHANCED LEARNING EXPERIENCE USING ADVANCED VISUALIZATION TECHNIQUES
  • 5.12.2 IMPROVED DETERMINATION AND SIMULATION OF LYMPH NODE BY 3D RECONSTRUCTION
  • 5.12.3 ENHANCED DECISION-MAKING AND TRACKING OF TUMOR PROGRESSION WITH VISUALIZATION TOOLS
• 5.13 REGULATORY LANDSCAPE
  • 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.13.2 REGULATORY ANALYSIS
• 5.14 PORTER'S FIVE FORCES ANALYSIS
  • 5.14.1 THREAT OF NEW ENTRANTS
  • 5.14.2 THREAT OF SUBSTITUTES
  • 5.14.3 BARGAINING POWER OF SUPPLIERS
  • 5.14.4 BARGAINING POWER OF BUYERS
  • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.15.2 BUYING CRITERIA
• 5.16 END-USER ANALYSIS
  • 5.16.1 UNMET NEEDS
  • 5.16.2 END-USER EXPECTATIONS
• 5.17 ADVANCED VISUALIZATION BUSINESS MODELS
  • 5.17.1 SUBSCRIPTION-BASED MODEL
  • 5.17.2 SAAS MODEL
  • 5.17.3 ENTERPRISE LICENSING
  • 5.17.4 FREEMIUM MODEL
  • 5.17.5 CONSULTING SERVICES MODEL
  • 5.17.6 PARTNERSHIP/REVENUE-SHARING MODEL
  • 5.17.7 HYBRID MODEL
  • 5.17.8 SERVICE MODEL
• 5.18 IMPACT OF AI/GENERATIVE AI ON ADVANCED VISUALIZATION MARKET
  • 5.18.1 INTRODUCTION
  • 5.18.2 MARKET POTENTIAL OF ADVANCED VISUALIZATION
  • 5.18.3 AI USE CASES IN ADVANCED VISUALIZATION
    • 5.18.3.1 Key use cases of AI
    • 5.18.3.2 Potential use cases of gen AI
  • 5.18.4 CASE STUDY
  • 5.18.5 IMPACT OF GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
    • 5.18.5.1 Diagnostic procedures
    • 5.18.5.2 Personalized treatment
    • 5.18.5.3 Predictive patient care
    • 5.18.5.4 Operational efficiency
    • 5.18.5.5 Healthcare imaging
  • 5.18.6 USER READINESS AND IMPACT ASSESSMENT
    • 5.18.6.1 User readiness
      • 5.18.6.1.1 Hospitals & ambulatory surgical centers
      • 5.18.6.1.2 Diagnostic & imaging centers
      • 5.18.6.1.3 Academic & research centers
    • 5.18.6.2 Impact assessment
      • 5.18.6.2.1 User A: Hospitals & ambulatory surgical centers
        • 5.18.6.2.1.1 Implementation
        • 5.18.6.2.1.2 Impact
      • 5.18.6.2.2 User B: Diagnostic & imaging centers
        • 5.18.6.2.2.1 Implementation
        • 5.18.6.2.2.2 Impact
      • 5.18.6.2.3 User C: Academic & research centers
        • 5.18.6.2.3.1 Implementation
        • 5.18.6.2.3.2 Impact

6 ADVANCED VISUALIZATION MARKET, BY OFFERING

• 6.1 INTRODUCTION
• 6.2 SERVICES
  • 6.2.1 IMPLEMENTATION SERVICES
    • 6.2.1.1 Rising installation of advanced visualization solutions in hospitals & diagnostic centers to sustain growth
  • 6.2.2 CONSULTING/OPTIMIZATION SERVICES
    • 6.2.2.1 Increasing adoption of enhanced workflow practices to support growth
  • 6.2.3 TRAINING & EDUCATION SERVICES
    • 6.2.3.1 Growing adoption of technologically advanced 3D imaging software to drive market
  • 6.2.4 POST-SALES & MAINTENANCE SERVICES
    • 6.2.4.1 Increasing availability of advanced visualization solutions to propel market
• 6.3 SOFTWARE
  • 6.3.1 ON-PREMISE SOFTWARE
    • 6.3.1.1 Rising focus on enhanced patient care and operational efficiency to augment growth
  • 6.3.2 CLOUD-BASED SOFTWARE
    • 6.3.2.1 Increasing demand for remote healthcare services and telemedicine to accelerate growth
• 6.4 HARDWARE
  • 6.4.1 GROWING DEMAND FOR HIGH-QUALITY IMAGING IN SPECIALIZED FIELDS TO BOOST MARKET

7 ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE

• 7.1 INTRODUCTION
• 7.2 ENTERPRISE-WIDE THIN CLIENT-BASED SOLUTIONS
  • 7.2.1 NEED TO IMPROVE DIAGNOSTIC CAPABILITIES ACROSS HEALTHCARE FACILITIES TO DRIVE MARKET
• 7.3 STANDALONE WORKSTATION-BASED SOLUTIONS
  • 7.3.1 INCREASING COMPLEXITY OF MEDICAL IMAGING DATA TO FACILITATE GROWTH

8 ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY

• 8.1 INTRODUCTION
• 8.2 MAGNETIC RESONANCE IMAGING
  • 8.2.1 INCREASING INSTALLATIONS OF MAGNETIC RESONANCE IMAGING MACHINES TO SUSTAIN GROWTH
• 8.3 COMPUTED TOMOGRAPHY
  • 8.3.1 RISING NEED FOR PRECISE ASSESSMENT OF COMPLEX ANATOMICAL STRUCTURES TO DRIVE MARKET
• 8.4 POSITRON EMISSION TOMOGRAPHY
  • 8.4.1 GROWING ADOPTION OF ADVANCED VISUALIZATION IN ONCOLOGY, NEUROLOGY, AND CARDIOLOGY TO BOOST MARKET
• 8.5 ULTRASOUND
  • 8.5.1 GROWING PREFERENCE OF HEALTHCARE PROFESSIONALS FOR ADVANCED ULTRASOUND TO PROPEL MARKET
• 8.6 RADIOTHERAPY
  • 8.6.1 RISING DEMAND FOR PERSONALIZED AND PRECISE CANCER TREATMENT TO PROMOTE GROWTH
• 8.7 NUCLEAR MEDICINE
  • 8.7.1 NEED TO ASSESS HEALTH AND FUNCTIONING OF CRITICAL ORGANS TO SUPPORT GROWTH
• 8.8 OTHER IMAGING MODALITIES

9 ADVANCED VISUALIZATION MARKET, BY APPLICATION

• 9.1 INTRODUCTION
• 9.2 RADIOLOGICAL/INTERVENTIONAL RADIOLOGICAL APPLICATIONS
  • 9.2.1 ONGOING TREND OF PROCESS AUTOMATION AND WORKFLOW DIGITIZATION TO AUGMENT GROWTH
• 9.3 CARDIOLOGICAL APPLICATIONS
  • 9.3.1 GROWING INCIDENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
• 9.4 ORTHOPEDIC APPLICATIONS
  • 9.4.1 INCREASING ADVANCEMENTS IN HOLOGRAPHIC TECHNOLOGY AND VIRTUAL REALITY TO EXPEDITE GROWTH
• 9.5 ONCOLOGICAL APPLICATIONS
  • 9.5.1 RISING INCIDENCE OF CANCER TO CONTRIBUTE TO SEGMENT GROWTH
• 9.6 VASCULAR APPLICATIONS
  • 9.6.1 NEED FOR PRECISE IMAGING TO SUSTAIN GROWTH
• 9.7 NEUROLOGICAL APPLICATIONS
  • 9.7.1 GROWING ADVANCEMENTS IN NEUROIMAGING TECHNIQUES TO FUEL MARKET
• 9.8 OTHER APPLICATIONS

10 ADVANCED VISUALIZATION MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 HOSPITALS & AMBULATORY SURGICAL CENTERS
  • 10.2.1 HIGH ADOPTION RATE OF DIAGNOSTIC PROCEDURES FOR EARLY DISEASE DETECTION TO CONTRIBUTE TO GROWTH
• 10.3 DIAGNOSTIC & IMAGING CENTERS
  • 10.3.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO FAVOR GROWTH
• 10.4 ACADEMIC & RESEARCH CENTERS
  • 10.4.1 GROWING NUMBER OF FUNDS AND GRANTS FOR RESEARCH ACTIVITIES TO DRIVE MARKET
• 10.5 OTHER END USERS

11 ADVANCED VISUALIZATION MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 Continuous technological advancements in diagnostic imaging modalities to promote growth
  • 11.2.3 CANADA
    • 11.2.3.1 Increasing prevalence of heart ailments to expedite growth
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 GERMANY
    • 11.3.2.1 Rapid growth of diagnostic imaging research activities and outsourcing of testing to boost market
  • 11.3.3 UK
    • 11.3.3.1 Rising acceptance of advanced diagnostic imaging techniques to aid growth
  • 11.3.4 FRANCE
    • 11.3.4.1 Easy accessibility to diagnostic assay procedures and availability of low-cost surgical facilities to spur growth
  • 11.3.5 SPAIN
    • 11.3.5.1 Increasing access to advanced cancer screening programs to stimulate growth
  • 11.3.6 ITALY
    • 11.3.6.1 Growing adoption of digitized diagnostic techniques to fuel market
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 JAPAN
    • 11.4.2.1 Favorable reimbursement system and growing access to healthcare systems to propel market
  • 11.4.3 CHINA
    • 11.4.3.1 Changing lifestyle and growing purchasing power to accelerate growth
  • 11.4.4 INDIA
    • 11.4.4.1 Rising trend of medical tourism to augment growth
  • 11.4.5 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 Free and universal public health system to contribute to market growth
  • 11.5.3 MEXICO
    • 11.5.3.1 Growing adoption of advanced devices to fuel market
  • 11.5.4 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.6.2 GCC COUNTRIES
    • 11.6.2.1 Growing focus on improving healthcare services and infrastructure to drive market
  • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2021-DECEMBER 2024
• 12.3 REVENUE ANALYSIS, 2019-2023
• 12.4 MARKET SHARE ANALYSIS, 2023
• 12.5 COMPANY VALUATION AND FINANCIAL METRICS
• 12.6 BRAND/PRODUCT COMPARISON
• 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.7.1 STARS
  • 12.7.2 EMERGING LEADERS
  • 12.7.3 PERVASIVE PLAYERS
  • 12.7.4 PARTICIPANTS
  • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 12.7.5.1 Company footprint
    • 12.7.5.2 Application footprint
    • 12.7.5.3 Solution type footprint
    • 12.7.5.4 Imaging modality footprint
    • 12.7.5.5 Component footprint
    • 12.7.5.6 End-user footprint
    • 12.7.5.7 Region footprint
• 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 12.8.1 PROGRESSIVE COMPANIES
  • 12.8.2 RESPONSIVE COMPANIES
  • 12.8.3 DYNAMIC COMPANIES
  • 12.8.4 STARTING BLOCKS
  • 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 12.8.5.1 Detailed list of key startups/SMEs
    • 12.8.5.2 Competitive benchmarking of key startups/SMEs
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES AND UPGRADES
  • 12.9.2 DEALS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 AGFA-GEVAERT GROUP
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products/Solutions/Services offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Deals
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Right to win
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses and competitive threats
  • 13.1.2 CANON MEDICAL SYSTEMS CORPORATION
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products/Solutions/Services offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Deals
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Right to win
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses and competitive threats
  • 13.1.3 FUJIFILM HOLDINGS CORPORATION
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products/Solutions/Services offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product launches and upgrades
      • 13.1.3.3.2 Deals
  • 13.1.4 GE HEALTHCARE
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products/Solutions/Services offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product launches and upgrades
      • 13.1.4.3.2 Deals
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Right to win
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses and competitive threats
  • 13.1.5 SIEMENS HEALTHINEERS AG
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products/Solutions/Services offered
    • 13.1.5.3 MnM view
      • 13.1.5.3.1 Right to win
      • 13.1.5.3.2 Strategic choices
      • 13.1.5.3.3 Weaknesses and competitive threats
  • 13.1.6 KONINKLIJKE PHILIPS N.V.
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products/Solutions/Services offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product launches and upgrades
      • 13.1.6.3.2 Deals
    • 13.1.6.4 MnM view
      • 13.1.6.4.1 Right to win
      • 13.1.6.4.2 Strategic choices
      • 13.1.6.4.3 Weaknesses and competitive threats
  • 13.1.7 STRYKER
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products/Solutions/Services offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Product launches and upgrades
      • 13.1.7.3.2 Deals
  • 13.1.8 CHANGE HEALTHCARE (UNITEDHEALTH GROUP)
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products/Solutions/Services offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Deals
  • 13.1.9 TERARECON
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products/Solutions/Services offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Product launches and upgrades
      • 13.1.9.3.2 Deals
  • 13.1.10 ZIOSOFT
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products/Solutions/Services offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Product launches and upgrades
  • 13.1.11 PRO MEDICUS, LTD.
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products/Solutions/Services offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Other Developments
  • 13.1.12 CARESTREAM HEALTH
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products/Solutions/Services offered
    • 13.1.12.3 Recent developments
      • 13.1.12.3.1 Product launches and upgrades
  • 13.1.13 FOVIA, INC.
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products/Solutions/Services offered
    • 13.1.13.3 Recent developments
      • 13.1.13.3.1 Deals
  • 13.1.14 4DMEDICAL
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products/Solutions/Services offered
    • 13.1.14.3 Recent developments
      • 13.1.14.3.1 Deals
  • 13.1.15 SYNOPSYS, INC.
    • 13.1.15.1 Business overview
    • 13.1.15.2 Products/Solutions/Services offered
    • 13.1.15.3 Recent developments
      • 13.1.15.3.1 Deals
  • 13.1.16 NOVARAD
    • 13.1.16.1 Business overview
    • 13.1.16.2 Products/Solutions/Services offered
  • 13.1.17 ANALYZEDIRECT, INC.
    • 13.1.17.1 Business overview
    • 13.1.17.2 Products/Solutions/Services offered
  • 13.1.18 SYNTERMED INC.
    • 13.1.18.1 Business overview
    • 13.1.18.2 Products/Solutions/Services offered
  • 13.1.19 PIE MEDICAL IMAGING B.V.
    • 13.1.19.1 Business overview
    • 13.1.19.2 Products/Solutions/Services offered
    • 13.1.19.3 Recent developments
      • 13.1.19.3.1 Product launches and upgrades
      • 13.1.19.3.2 Deals
  • 13.1.20 INFINITT HEALTHCARE CO., LTD.
    • 13.1.20.1 Business overview
    • 13.1.20.2 Products/Solutions/Services offered
    • 13.1.20.3 Recent developments
      • 13.1.20.3.1 Deals
• 13.2 OTHER PLAYERS
  • 13.2.1 BIOTRONICS 3D
  • 13.2.2 MINNOVAA INNOVATIONS OU
  • 13.2.3 POSTDICOM
  • 13.2.4 CITIUSTECH INC.
  • 13.2.5 CEEVRA, INC.

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS

관련자료